COMMUNIQUÉS West-GlobeNewswire

Auransa Enters into Exclusive Licensing Agreement with China Oncology Focus Limited, an Affiliate of Lee’s Pharmaceutical Holdings, for Rights to AU018 in Greater China and Southeast Asia

19/12/2018 - 13:05

Auransa to Receive Upfront Payment and be Eligible for Milestone Payments and Sales Royalties for Preclinical Program Identified by Company’s AI-Driven SMarTR™ Engine China Oncology Focus to Receive Rights to Develop [...]

EndoPredict® Test Receives Positive NICE Recommendation for Patients with Early Breast Cancer

19/12/2018 - 13:05

NICE Decision is a Major Milestone in Expanding Access to Patients in the UK SALT LAKE CITY, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today [...]

Dengvaxia® vaccine approved for prevention of dengue in Europe

19/12/2018 - 13:01

Dengvaxia ® vaccine approved for prevention of dengue in Europe Paris, France - December 19, 2018 - The European Commission has granted marketing authorization for Dengvaxia ® , Sanofi's dengue vaccine. The marketing [...]

Le vaccin Dengvaxia® est approuvé en Europe pour la prévention de la dengue

19/12/2018 - 13:01

Le vaccin Dengvaxia ® est approuvé en Europe pour la prévention de la dengue Paris, France - Le 19 décembre 2018 - La Commission européenne a délivré une autorisation de mise sur le marché de Dengvaxia ® , le vaccin de [...]

AVROBIO Receives Orphan-Drug Designation from the U.S. FDA for AVR RD 01 for the Treatment of Fabry Disease

19/12/2018 - 13:00

CAMBRIDGE, Mass., Dec. 19, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc. (NASDAQ:AVRO) (the “Company”), a Phase 2 clinical-stage gene therapy company developing gene therapies to potentially cure rare diseases with a single [...]

IRADIMED CORPORATION Announces 510(k) Clearance of Invasive Blood Pressure Module for use with its MRI-Compatible Patient Vital Signs Monitor

19/12/2018 - 13:00

WINTER SPRINGS, Fla., Dec. 19, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices, today announced FDA 510(k) [...]

Canopy Rivers Announces DTC Eligibility

19/12/2018 - 13:00

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES TORONTO, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (the “ Company ” or “ Canopy Rivers ”) (TSXV: RIV) is pleased to announce that its [...]

Immutep Announces US$5.2 Million Financing Led by U.S. Specialist Healthcare Investor, Altium Capital

19/12/2018 - 13:00

Extends the Company’s cash runway into mid-2020, during which time Immutep is expected to report meaningful clinical data SYDNEY, Australia, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (" [...]

Ziopharm Oncology and TriArm Therapeutics Establish Joint Venture to Develop and Commercialize Sleeping Beauty CAR T in China, Taiwan and Korea

19/12/2018 - 12:59

-- Joint venture to operate as Eden BioCell -- -- TriArm Therapeutics, a Panacea Venture Healthcare company, to fund Eden BioCell with up to $35M -- -- Ziopharm to license rights of third-generation Sleeping Beauty CD19 [...]

Phase II study: SCENESSE® in combination with narrowband ultraviolet B (NB-UVB) achieves repigmentation in vitiligo

19/12/2018 - 12:38

A new observation in the CUV103 study conducted in Singapore is that overall skin darkening is culturally and socially unacceptable among patients of Asian origin MELBOURNE, Australia and SINGAPORE, Dec. 19, 2018 (GLOBE [...]

AC Immune and WuXi Biologics to Establish an Exclusive Strategic Partnership

19/12/2018 - 12:31

AC Immune to draw on WuXi Biologics' expertise in manufacturing innovative New Biological Entities against CNS disorders including proprietary WuXiUP continuous manufacturing platform that can significantly reduce cost [...]

Aleafia Health Inc. to Acquire Emblem Corp. to Create New Medical Cannabis Leader

19/12/2018 - 12:20

Combination will create Canada’s largest medical cannabis clinic network with access to 40 medical clinics and education centres; Aleafia patients to access Emblem’s differentiated, high margin derivative products [...]

Avinger Announces Preliminary Analysis of Results from SCAN Clinical Study

19/12/2018 - 12:00

OCT Imaging with Pantheris Superior or Equivalent to IVUS on all Parameters REDWOOD CITY, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for [...]

Xbrane Biopharma has submitted the first application for start of Xlucane clinical trial

19/12/2018 - 10:01

Press release 2018-12-19 Xbrane Biopharma has submitted its first national Clinical Trial Application (CTA) to the Food and Drug Administration (FDA) in the United States for the start of the Xplore trial for Xlucane, [...]

Medtronic Completes Acquisition of Mazor Robotics

19/12/2018 - 08:13

Company Integrates Robotics and Aims to Make Spine Surgery More Predictable and T ransform Outcomes for Hospitals, Surgeons, and Patients DUBLIN - December 19, 2018 - Medtronic plc (NYSE:MDT) today announced it has [...]

Press release: Terveystalo continues to grow its footprint in well-being services: Kuntoutumisasema OTE Oy to become part of Terveystalo

19/12/2018 - 08:01

On 14 December, Terveystalo signed a contract on acquiring the operations of Kuntoutumisasema OTE Oy. The acquisition is already fourth deal in the area of well-being services during this year. The company's employees [...]

Sandoz enters into commercialization and supply agreement for insulin biosimilars, anticipating growing demand as diabetes burden rises

19/12/2018 - 07:15

Agreement covers biosimilar insulins in early and clinical development for the top three selling branded insulins by sales: glargine, lispro and aspart Over 400 million people worldwide have diabetes and the amount of [...]

Alcon Announces Acquisition of Tear Film Innovations, Inc.

19/12/2018 - 07:10

Acquisition further expands Alcon's portfolio of comprehensive solutions for patients with dry eye Tear Film's iLux ® Device offers innovative, customizable treatment for Meibomian Gland Dysfunction, a leading cause of [...]

Pain Therapeutics Announces Filing of Registration Statement on SEC Form S-1

19/12/2018 - 00:00

Filing Will Register Common Stock for Previously Issued Warrants AUSTIN, Texas, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE) today announced the filing of a registration statement on Form S-1 [...]